
A three-judge panel of the 9th US Circuit Court of Appeals weighed dueling arguments Tuesday in Intel’s bid to revive its antitrust lawsuit against SoftBank-owned Fortress.
The panel voiced some skepticism of Intel’s argument that Fortress and affiliated entities broke US antitrust law by stockpiling patents and using them to extort tech companies.
VLSI Technology, which is owned by investment funds that Fortress manages, won $2.2 billion from Intel in a patent case in Texas last year and has other lawsuits pending against the chipmaker.
Intel and Apple Inc sued Fortress in 2019 for alleged antitrust violations based on its patent activities. Apple withdrew from the case last year, and US District Judge Edward Chen dismissed the lawsuit months later.
Chen found that Intel had failed to show Fortress’ patent aggregation had anti-competitive effects on pricing.
US Circuit Judges Mary Schroeder, Johnnie Rawlinson and Daniel Bress on Tuesday grilled Intel attorney Seth Waxman of Wilmer Cutler Pickering Hale & Dorr about his definition of “pricing,” which he said were the royalties that Fortress-related entities would demand to use the patented technology.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas